The International NPC registry, a prospective observational cohort study, included 163 NPC patients from 14 European countries, Australia, Brazil, and Canada and 137 patients had available genetic results; 134 had NPC1 and three had NPC2 mutations. This evidence concerns the gene NPC2 and nasopharyngeal carcinoma.